A patient with Schizophrenia has been on antipsychotic medication to help with positive and negative symptoms. Which drug do you expect this to be

Reasoning: Choice A reason: Zyprexa, or olanzapine, is a second-generation atypical antipsychotic. Unlike first-generation drugs, it antagonizes both dopamine D2 and serotonin 5-HT2A receptors. This dual mechanism allows it to effectively treat positive symptoms like hallucinations while also significantly improving negative symptoms such as social withdrawal, alogia, and flattened affect. Choice B reason: Haldol, or haloperidol, is a first-generation typical antipsychotic that primarily targets D2 receptors. While it is highly effective at reducing positive symptoms like delusions and agitation, it is generally ineffective for negative symptoms. In some cases, it may even exacerbate negative symptoms due to its potent dopamine blockade. Choice C reason: Lorazepam is a benzodiazepine used primarily to manage acute anxiety, agitation, or catatonic features in psychiatric patients. It is not classified as an antipsychotic and does not treat the underlying pathophysiology of schizophrenia. It has no efficacy in reducing the chronic positive or negative symptoms of the disorder. Choice D reason: Loxapine is a first-generation or "typical" antipsychotic, although it sometimes displays properties similar to atypicals. Its primary clinical use is focused on treating positive symptoms of psychosis. It lacks the robust serotonergic activity required to be the expected choice for specifically addressing the negative symptoms of schizophrenia.